Introduction INYLTA TABLET:

Inylta 5mg, containing the active ingredient Axitinib, is a tyrosine kinase inhibitor used to deal with advanced kidney cancer (renal cell carcinoma). This drug can harm a fetus, so inform your doctor if you are pregnant or planning to conceive. Both men and women should use birth control during treatment and for one week after the last dose. Do not breastfeed during treatment, as it may affect the baby's development.

It is not advisable for use in children and adolescents under 18 years old. Urgently contact your healthcare provider if you develop symptoms like arrhythmia, chest pain, or a persistent cough. Your doctor may require regular monitoring of your white blood cells, platelets, blood sugar, electrolytes, and kidney function to avert complications. Additionally, report any digestive symptoms such as diarrhoea, nausea, vomiting, or constipation to your healthcare provider without delay.

Uses of INYLTA TABLET:

• Targets specific enzymes to prevent the growth and spread of cancer cells.
• Aids in reducing symptoms associated with advanced kidney cancer, improving the patient's quality of life.

How to consume INYLTA TABLET:

Your doctor will decide the dose and duration of Inylta 5mg tablet based on the disease condition. Always take this medicine as prescribed by your doctor. The recommended starting oral dose is 5 mg twice daily. Take the tablet at the same time every day, with or without food. Do not chew, crush, or break the tablet. Swallow the whole tablet with water. If you forgot to take the tablet, simply take your next dose at the scheduled time. Do not take a double dose to make up for a forgotten dose..